Addendum re NVS-Alcon machinations: Inasmuch as NVS will be requited to shell out something in the neighborhood of $20B to satisfy Nestlé’s put option, the Alcon transaction is germane to investors in any biotech company in which NVS might have a buyout interest, including such companies as MNTA and IDIX.
Market Data 
Markets 
AI
